Article info
PDFEpidemiology
Research
Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case–control study
- Correspondence to Dr Hui-Chun Tsuang; hctsuang{at}gmail.com
Citation
Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case–control study
Publication history
- Received October 6, 2017
- Revised February 23, 2018
- Accepted February 27, 2018
- First published May 24, 2018.
Online issue publication
February 20, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/